Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Declines By 50.0%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling 400 shares, a drop of 50.0% from the September 15th total of 800 shares. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is currently 0.1 days.

F/m Emerald Life Sciences Innovation ETF Price Performance

Shares of F/m Emerald Life Sciences Innovation ETF stock opened at $30.99 on Wednesday. The business has a fifty day simple moving average of $28.83 and a two-hundred day simple moving average of $25.39. F/m Emerald Life Sciences Innovation ETF has a 12 month low of $18.78 and a 12 month high of $31.43.

Hedge Funds Weigh In On F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC raised its position in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 44.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,639 shares of the company’s stock after buying an additional 11,329 shares during the quarter. Hunter Associates Investment Management LLC owned about 1.64% of F/m Emerald Life Sciences Innovation ETF worth $820,000 at the end of the most recent quarter.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.